Related Experiment Video
Updated: Jul 31, 2025
13:53
Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
5.1K
Preparation a Recombinant Form of Pneumolysin Protein from Streptococcus pneumoniae
D S Vorobyev1, A V Sidorov2, A A Kaloshin2
1I. I. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia. vorobievdenis@yandex.ru.
Bulletin of Experimental Biology and Medicine
|May 10, 2023
Summary
Researchers successfully produced a recombinant pneumolysin protein from Streptococcus pneumoniae. This involves gene amplification, expression in E. coli, and purification for potential therapeutic applications.
Area of Science:
- Microbiology
- Molecular Biology
- Protein Expression
Background:
- Streptococcus pneumoniae causes severe infections.
- Pneumolysin is a key virulence factor of S. pneumoniae.
- Recombinant pneumolysin production is crucial for vaccine development.
Purpose of the Study:
- To construct an expression system for recombinant pneumolysin from S. pneumoniae.
- To obtain a purified recombinant pneumolysin protein for further studies.
Main Methods:
- Bioinformatic analysis using Vector NTI Advance 11.0 for primer design.
- Polymerase Chain Reaction (PCR) to amplify the pneumolysin gene fragment.
- Recombinant protein expression in E. coli M15 strain.
- Affinity chromatography using Ni-Sepharose for protein purification.
- Immunoblotting for confirmation of recombinant pneumolysin.
Main Results:
- A specific PCR product encoding full-length pneumolysin was obtained.
- Recombinant pneumolysin was successfully synthesized and expressed in E. coli.
- Purified recombinant pneumolysin was confirmed by immunoblotting.
Conclusions:
- A functional expression system for recombinant pneumolysin was established.
- The recombinant protein can be purified and confirmed using standard molecular biology techniques.
- This work provides a foundation for developing pneumococcal vaccines and therapeutics.
